NDC product
Diazepam
NDC 43598-106 · Dr. Reddy's Laboratories Inc
Key facts
| Product NDC | 43598-106 |
|---|---|
| Proprietary name | Diazepam |
| Nonproprietary name | DIAZEPAM |
| Substances | DIAZEPAM |
| Dosage form | INJECTION, SOLUTION |
| Route | INTRAMUSCULAR, INTRAVENOUS |
| Labeler | Dr. Reddy's Laboratories Inc |
| Product type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Application number | ANDA218422 |
| DEA schedule | CIV |
| Pharmacologic classes | Benzodiazepine [EPC], Benzodiazepines [CS] |
| Marketing start | Aug 7, 2024 |
| Marketing end | Jul 23, 2027 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory